INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Appropriations History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹37 Cr | ₹31 Cr | ₹22 Cr | ₹16 Cr | ₹11 Cr |
What is the latest Appropriations of INDO US BIOTECH ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹22 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹11 Cr |
How is Appropriations of INDO US BIOTECH Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 20.39 | |
| Mar2024 | ₹31 Cr | 36.92 | |
| Mar2023 | ₹22 Cr | 35.66 | |
| Mar2022 | ₹16 Cr | 46.60 | |
| Mar2021 | ₹11 Cr | - | |
Compare Appropriations of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹178.9 Cr | -1.4% | -11.9% | -41.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,760.4 Cr | 9% | 3% | -26.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,997.8 Cr | -0.4% | -6.5% | -10.8% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,064.8 Cr | -3.4% | 2.2% | 8.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹926.6 Cr | -2.4% | -8.8% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹527.3 Cr | 1.6% | 17.7% | 13.6% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -1.4% |
-11.9% |
-41.4% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses